Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Fernando C Maluf"'
Autor:
Aknar FC Calabrich, Daniele Xavier Assad, Graziela Dal-Molin, Andreia C Melo, Angelica Nogueira-Rodrigues, Karime Kalil, Andrea PG Guimarães, Michelle Samora Almeida, Carla Rameri de Azevedo, Daniela de Freitas, Alessandra Menezes Morelle, Ana Carolina Leite, Marcela Crosara, João Soares Nunes, Poliana Signorini, Eduardo Cronemberger, Rachel Cossetti, Rodrigo Guindalini, Eduardo Paulino, Fernando C Maluf
Publikováno v:
Brazilian Journal of Oncology, Vol 19 (2023)
To report consensus recommendations on the current role of poly(ADP-ribose) polymerase (PARP) inhibitors in the front-line management of patients with epithelial ovarian cancer (EOC) in the healthcare setting of Brazil. The expert panel convened in M
Externí odkaz:
https://doaj.org/article/625f675b06584ac3b0c5e8d00b722bfb
Autor:
Lucas Nogueira, Icaro Thiago de Carvalho, Ary Adamy, Daher Chade, Luis Felipe Piovesan, Ricardo Favaretto, Allisson Bruno Barcelos Borges, Arthur Accioly, Diogo Assed Bastos, Diogo Augusto Rodrigues da Rosa, Fernando C Maluf, Andrey Soares
Publikováno v:
Brazilian Journal of Oncology, Vol 17, Iss 00 (2021)
Introduction: Urothelial carcinoma, especially localized bladder cancer, has a substantial prevalence in Brazil with 9,480 new cases each year and 3,903 deaths, therefore progress is required in its management in order to decrease its recurrence and
Externí odkaz:
https://doaj.org/article/497433a85e944b4baec3335a578457b5
Publikováno v:
Gynecologic Oncology Reports, Vol 22, Iss C, Pp 37-39 (2017)
Yolk sac tumor (YST) is the second most common subtype of ovarian germ cell tumors. It usually occurs in the second and third decades of life and is rare in postmenopausal women. In postmenopausal women, YST is commonly an aggressive tumor and can pr
Externí odkaz:
https://doaj.org/article/4b8a510aeaa848669afe2486d4eadbe5
Autor:
Jose Edson Pontes, João Victor Salvajoli, Daniel Moore Freitas Palhares, Gustavo Cardoso Guimarães, Erlon Gil, Rodrigo Antonio Ledezma Roja, William C. Nahas, Ronaldo Hueb Baroni, Marco A. Arap, Rafael Coelho, Leopoldo Alves Ribeiro Filho, Douglas Racy, Wladimir Alfer, Ivan Frederico Pinto Gimpel, Raja B. Khauli, Fernando Freire de Arruda, Bernardo Peres Salvajoli, Marcus Vinicius Sadi, Robson Ferrigno, Gustavo Caserta Lemos, Lucas Nogueira, Jose Luis Chambo, Icaro Thiago de Carvalho, Marcelo Langer Wroclawski, Marcelo Roberto Pereira Freitas, Rodrigo de Moraes Hanriot, Pedro Luiz Serrano Uson Junior, Fernando C. Maluf, Rafael Gadia, Muhammad Bulbulan, Gustavo F. Carvalhal, Igor Austin Fernandes Martins, Stênio de Cássio Zequi
Publikováno v:
JCO Global Oncology
PURPOSE To generate and present survey results on important issues relevant to treatment and follow-up of localized and locally advanced, high-risk prostate cancer (PCa) focusing on developing countries. METHODS A panel of 99 PCa experts developed mo
Autor:
Aldo Lourenço Abbade Dettino, Fernando C. Maluf, Ariel Galapo Kann, João Francisco Navarro Reolon, Juan Jose Zarbá, Igor Alexandre Protzner Morbeck, Karine Martins da Trindade, Ana Paula Garcia Cardoso, José Augusto Rinck, Diego Emilio Lopera Cortés, André Seeke Sasse, Juan Pablo Sade, Adriano Gonçalves E Silva, Andrey Soares, Silke Gillessen, L. Costa, Manuel Caitano Maia, Denis Leonardo Fontes Jardim, Mariana Bruno Siqueira, Daniel Herchenhorn, Lucas V. dos Santos, Felipe Moraes Toledo Pereira, Fábio Roberto Kater
Publikováno v:
JCO Global Oncology
PURPOSE To present a summary of the recommendations for the treatment and follow-up for metastatic castration-resistant prostate cancer (mCRPC) as acquired through a questionnaire administered to 99 physicians working in the field of prostate cancer
Autor:
Sandro Roberto De Araujo Cavallero, Ray Antonio Manneh Kopp, Fernando Sabino Marques Monteiro, Rodrigo Nogueira Fogace, Diogo Assed Bastos, Fabio A.B. Schutz, Helena Paes de Almeida Saito, Pamela Salman Boghikian, Pedro Luiz Serrano Usón, Fernando C. Maluf, Fernando Vidigal de Pádua, Evanius Garcia Wiermann, Sergio Aguiar, Felipe Moraes Toledo Pereira, Mouna Ayadi, Fábio Roberto Kater, Diogo Augusto Rodrigues da Rosa, Ricardo Saraiva de Carvalho, Fernando Nunes Galvão de Oliveira, Francisco Javier Orlandi, Vinicius Carreira Souza, Silke Gillessen Sommer
Publikováno v:
JCO Global Oncology
PURPOSE International guideline recommendations may not always be extrapolated to developing countries where access to resources is limited. In metastatic castration-sensitive prostate cancer (mCSPC), there have been successful drug and imaging advan
Autor:
Fernando C. Maluf, Andreia Cristina de Melo, Angélica Nogueira-Rodrigues, Rachel P. Riechelmann, Denis Leonardo Fontes Jardim, Eva Bustamante, Daniela Dornelles Rosa, Gilberto de Castro, Gustavo Werutsky, Carlos Barrios, Henry Gomes, Maurício Fraga, Denisse Bretel, Raul Sala, Clarissa Mathias, William N. William, Andrés F. Cardona, Camilla Akemi Felizardo Yamada, Oscar Arrieta, Aline Bobato Lara Gongora, Diogo Assed Bastos
Publikováno v:
JCO Global Oncology
PURPOSE COVID-19 has affected cancer care worldwide. Clinical trials are an important alternative for the treatment of oncologic patients, especially in Latin America, where trials can be the only opportunity for some of them to access novel and, som
Autor:
Ricardo Azze Natel, Vinicius Carrera Souza, Lucas Mendes Nogueira, Fernando Sabino Marques Monteiro, Rodolfo Borges dos Reis, Karine Martins da Trindade, Igor Alexandre Protzner Morbeck, Renato Furoni, Aline Lury Hada, Arie Carneiro, Denis Leonardo Fontes Jardim, Livia Maria Querino da Silvo Andrade, Daniel Herchenhorn, Andrey Soares, Rodrigo Nogueira Fogace, Ana Paula Garcia Cardoso, Fernando C. Maluf, Guilherme Avanço, Felipe Moraes Toledo Pereira, Fábio Roberto Kater, João Francisco Navarro Reolon, Fabio A.B. Schutz
Publikováno v:
International Brazilian Journal of Urology, Vol 47, Iss 2, Pp 359-373 (2021)
International braz j urol v.47 n.2 2021
International Braz J Urol
Sociedade Brasileira de Urologia (SBU)
instacron:SBU
International Brazilian Journal of Urology : official journal of the Brazilian Society of Urology
International braz j urol, Volume: 47, Issue: 2, Pages: 359-373, Published: 05 FEB 2021
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
International braz j urol v.47 n.2 2021
International Braz J Urol
Sociedade Brasileira de Urologia (SBU)
instacron:SBU
International Brazilian Journal of Urology : official journal of the Brazilian Society of Urology
International braz j urol, Volume: 47, Issue: 2, Pages: 359-373, Published: 05 FEB 2021
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Background: Non-metastatic castration resistant prostate cancer (M0 CRPC) has seen important developments in drugs and diagnostic tools in the last two years. New hormonal agents have demonstrated improvement in metastasis free survival in M0 CRPC pa
Autor:
Fernando Korkes, Fernando C. Maluf
Publikováno v:
International Brazilian Journal of Urology, Vol 47, Iss 2, Pp 443-447 (2021)
International Brazilian Journal of Urology : official journal of the Brazilian Society of Urology
International Brazilian Journal of Urology : official journal of the Brazilian Society of Urology
Autor:
Charles G. Drake, Matthew R. Smith, Almudena Zapatero, Charles J. Ryan, Philip W. Kantoff, Piet Ost, Inge M. van Oort, Ian D. Davis, Nicolas James, Matthew R. Sydes, Vedang Murthy, Martin E. Gleave, Maha Hussain, Michael S Hofman, Susan Halabi, Ignacio Duran, Oliver Sartor, Raya Leibowitz, Christopher P. Evans, Anders Bjartell, Ros Eeles, Mack Roach, Hiroyoshi Suzuki, Colin C. Pritchard, Levent Türkeri, Daniel Heinrich, Fred Saad, William Oh, Karim Fizazi, Himisha Beltran, Declan G. Murphy, Joe M. O'Sullivan, Thomas Steuber, Raja B. Khauli, Axel Heidenreich, Silke Gillessen, Eric J. Small, Robert E. Reiter, Juan Pablo Sade, Chris Logothetis, Tomasz M. Beer, Alberto Briganti, Mary-Ellen Taplin, Johann S. de Bono, Howard I. Scher, Eleni Efstathiou, Stefano Fanti, Darren M.C. Poon, Felix Y. Feng, Aurelius Omlin, Hind Mrabti, Chris Parker, Anwar R. Padhani, Kim N. Chi, Mark A. Rubin, Neal D. Shore, Nicolas Mottet, Alicia K. Morgans, Christopher Sweeney, Mark Frydenberg, Robert G. Bristow, Fernando C. Maluf, Robin Millman, Cora N. Sternberg, Ravindran Kanesvaran, Michael J. Morris, Noel W. Clarke, Gerhardt Attard, Alberto Bossi, Bertrand Tombal, Celestia S. Higano, Howard R. Soule
Publikováno v:
EUROPEAN UROLOGY
European Urology, Vol. 77, no. 4, p. 508-547 (2020)
European Urology, 77, 508-547
European urology, vol 77, iss 4
European Urology, 77, 4, pp. 508-547
European Urology, Vol. 77, no. 4, p. 508-547 (2020)
European Urology, 77, 508-547
European urology, vol 77, iss 4
European Urology, 77, 4, pp. 508-547
Background: Innovations in treatments, imaging, and molecular characterisation in advanced prostate cancer have improved outcomes, but there are still many aspects of management that lack high-level evidence to inform clinical practice. The Advanced